NO307366B1 - Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten

Info

Publication number
NO307366B1
NO307366B1 NO962547A NO962547A NO307366B1 NO 307366 B1 NO307366 B1 NO 307366B1 NO 962547 A NO962547 A NO 962547A NO 962547 A NO962547 A NO 962547A NO 307366 B1 NO307366 B1 NO 307366B1
Authority
NO
Norway
Prior art keywords
preparation
tablets containing
tablet formulation
formulation prepared
containing paroxetine
Prior art date
Application number
NO962547A
Other languages
English (en)
Norwegian (no)
Other versions
NO962547L (no
NO962547D0 (no
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO307366(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO962547L publication Critical patent/NO962547L/no
Publication of NO962547D0 publication Critical patent/NO962547D0/no
Publication of NO307366B1 publication Critical patent/NO307366B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO962547A 1993-12-15 1996-06-14 Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten NO307366B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (3)

Publication Number Publication Date
NO962547L NO962547L (no) 1996-06-14
NO962547D0 NO962547D0 (no) 1996-06-14
NO307366B1 true NO307366B1 (no) 2000-03-27

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962547A NO307366B1 (no) 1993-12-15 1996-06-14 Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten

Country Status (36)

Country Link
US (1) US6113944A (ru)
EP (1) EP0734260B2 (ru)
JP (1) JP3037757B2 (ru)
KR (1) KR100367796B1 (ru)
CN (1) CN1071116C (ru)
AP (1) AP540A (ru)
AT (1) ATE180973T1 (ru)
AU (1) AU697982B2 (ru)
BG (1) BG62755B1 (ru)
BR (1) BR9408219A (ru)
CA (4) CA2214575C (ru)
CZ (1) CZ287891B6 (ru)
DE (1) DE69419033T2 (ru)
DK (1) DK0734260T4 (ru)
DZ (1) DZ1835A1 (ru)
ES (1) ES2132610T5 (ru)
FI (1) FI962445A0 (ru)
GB (1) GB9325644D0 (ru)
GR (1) GR3031047T3 (ru)
HK (1) HK1012285A1 (ru)
HU (1) HUT75880A (ru)
IL (1) IL111978A (ru)
MA (1) MA23395A1 (ru)
MY (1) MY112123A (ru)
NO (1) NO307366B1 (ru)
NZ (1) NZ277790A (ru)
OA (1) OA10297A (ru)
PL (1) PL314980A1 (ru)
RO (1) RO115413B1 (ru)
RU (1) RU2146141C1 (ru)
SA (1) SA94150373B1 (ru)
SI (1) SI0734260T2 (ru)
SK (1) SK282620B6 (ru)
UA (1) UA42745C2 (ru)
WO (1) WO1995016448A1 (ru)
ZA (1) ZA949900B (ru)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EE03970B1 (et) 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
AU5078700A (en) * 1999-06-22 2001-01-09 Smithkline Beecham Plc Novel composition
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
AU2001296084A1 (en) * 2000-08-28 2002-03-13 Synthon B.V. Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
DK1522539T3 (da) 2001-07-31 2007-05-07 Lundbeck & Co As H Krystallinsk komposition indeholdende excitalopram
DK1440067T3 (da) * 2001-10-22 2005-04-11 Synthon Bv N-formyl-derivater af paroxetin
IL162666A0 (en) * 2001-12-28 2005-11-20 Teva Pharma A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CA2574766A1 (en) * 2004-06-23 2006-01-26 Merck & Co., Inc. Estrogen receptor modulators
WO2006018318A1 (en) * 2004-08-18 2006-02-23 Synthon B.V. Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
EP1948646A2 (en) * 2005-11-14 2008-07-30 Auspex Pharmaceuticals Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (ru) * 1974-03-04 1975-09-11
ZA813205B (en) † 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
CA2096853A1 (en) * 1990-11-24 1992-05-25 Anthony Michael Johnson Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
CZ176396A3 (en) 1996-09-11
EP0734260A1 (en) 1996-10-02
NO962547L (no) 1996-06-14
CN1137236A (zh) 1996-12-04
CZ287891B6 (cs) 2001-03-14
IL111978A (en) 2000-07-16
DK0734260T3 (da) 1999-11-15
KR100367796B1 (ko) 2003-07-22
CA2178637C (en) 1997-12-23
ES2132610T3 (es) 1999-08-16
AP9400704A0 (en) 1995-01-31
BR9408219A (pt) 1997-08-26
ATE180973T1 (de) 1999-06-15
CA2214575C (en) 1999-12-07
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
FI962445A (fi) 1996-06-12
ES2132610T5 (es) 2008-12-16
WO1995016448A1 (en) 1995-06-22
AU1314595A (en) 1995-07-03
AU697982B2 (en) 1998-10-22
SA94150373B1 (ar) 2006-05-27
US6113944A (en) 2000-09-05
CA2214575A1 (en) 1995-06-22
SK282620B6 (sk) 2002-10-08
GR3031047T3 (en) 1999-12-31
AP540A (en) 1996-09-20
BG62755B1 (bg) 2000-07-31
HK1012285A1 (en) 1999-07-30
FI962445A0 (fi) 1996-06-12
EP0734260B1 (en) 1999-06-09
RU2146141C1 (ru) 2000-03-10
HU9601665D0 (en) 1996-08-28
SI0734260T2 (sl) 2008-12-31
GB9325644D0 (en) 1994-02-16
HUT75880A (en) 1997-05-28
MY112123A (en) 2001-04-30
UA42745C2 (ru) 2001-11-15
CA2274387A1 (en) 1995-06-22
CN1071116C (zh) 2001-09-19
DZ1835A1 (fr) 2002-02-17
EP0734260B2 (en) 2008-07-09
RO115413B1 (ro) 2000-02-28
CA2178637A1 (en) 1995-06-22
DE69419033D1 (de) 1999-07-15
JP3037757B2 (ja) 2000-05-08
NZ277790A (en) 1998-02-26
ZA949900B (en) 1995-10-10
JPH09506602A (ja) 1997-06-30
SA94150373A (ar) 2005-12-03
DE69419033T2 (de) 1999-11-25
PL314980A1 (en) 1996-09-30
DK0734260T4 (da) 2008-09-29
CA2274389C (en) 2004-09-14
NO962547D0 (no) 1996-06-14
CA2274389A1 (en) 1995-06-22
SI0734260T1 (en) 1999-08-31
MA23395A1 (fr) 1995-07-01
IL111978A0 (en) 1995-03-15
BG100648A (bg) 1997-02-28

Similar Documents

Publication Publication Date Title
NO307366B1 (no) Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
PL299176A1 (en) Novel heterocyclic compounds, pharmaceutical agent, method of obtaining such novel heterocyclic compounds and initial compounds for obtaining them
HUP9900467A3 (en) Novel acid-labile pharmaceutical composition containing omeprazole and process for its preparation
NO173588C (no) Fremgangsmaate for kontinuerlig fremstilling av tabletter og anordning for utfoerelse av fremgangsmaaten
HUT58326A (en) Process for producing pipeidine derivatives and pharmaceutical compositions containing them
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
HUT59389A (en) Process for producing heterocyclic compounds and pharmaceutical compositions comprising same
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
PL301281A1 (en) Novel organic compounds, method of obtaining such novel compounds and pharmaceutical composition containing them
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
HU9402187D0 (en) Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
HUT54695A (en) Process for producing new acetylcholinesteraze inhibitors and pharmaceutical compositions containing them
NO306717B1 (no) Fremgangsmåte for fremstilling av piperidin-karbinoler
HUT54378A (en) Process for producing squalene-synthetaze inhibitors containing phosphours and pharmaceutical compositions containing them
HUT54146A (en) Process for producing new benzodioxole derivatives and pharmaceutical compositions comprising such compounds
HUT56373A (en) Process for producing pyranobenzoxadiazole derivatives and pharmaceutical compositions comprising such compounds
HUT48210A (en) Process for producing new tetrahydropyridine derivatives and pharmaceutical compositions comprising such compounds
NO308004B1 (no) Nye aminofenylfosfonsyreforbindelser og farmasøytiske sammensetninger inneholdende dem
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
NO943826D0 (no) Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede
HUT55016A (en) Process for producing indolobenzoquinoline derivatives and pharmaceutical compositions comprising such compounds
HUT56065A (en) Process for producing tetrahydropyridine derivatives and pharmaceutical compositions containing them
PL308417A1 (en) Novel heterocyclic compounds, pharmaceutical compositions containing them and method of obtaining such compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees